A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells

DOI: 10.1080/2162402X.2017.1349589

Keywords: EMT, fusion protein, immunotherapy, NSCLC, PD-L1, TGF-β1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text